We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo WHX Labs Dubai 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lung Progenitor Cells Enable Culture of 3D Organoids for Studies

By LabMedica International staff writers
Posted on 15 Mar 2018
Image: Mouse (left) and human (right) alveolar progenitor cells grow into large lung organoids in culture, and make multiple types of epithelial cells including gas exchange type 1 cells (red) and surfactant-producing type 2 cells (green) (Photo courtesy of the Morrisey Laboratory, University of Pennsylvania).
Image: Mouse (left) and human (right) alveolar progenitor cells grow into large lung organoids in culture, and make multiple types of epithelial cells including gas exchange type 1 cells (red) and surfactant-producing type 2 cells (green) (Photo courtesy of the Morrisey Laboratory, University of Pennsylvania).
An in vitro system for growth of three-dimensional lung organoids was used to characterize a line of alveolar stem cells that plays a critical role in repairing lung tissues damaged by severe influenza or other respiratory ailments such as chronic obstructive pulmonary disease (COPD).

Functional tissue regeneration is required for the restoration of normal organ function after severe injury. Some organs, such as the intestine, harbor active stem cells throughout homeostasis and regeneration; more quiescent organs, such as the lung, often contain facultative progenitor cells that are recruited after injury to participate in regeneration.

To better understand the processes involved in lung tissue regeneration, investigators at the University of Pennsylvania (Philadelphia, USA) examined the epithelial cells that line the surfaces of lung gas-exchange alveoli for stem cell behavior that could restore normal respiratory function after severe injury.

The investigators reported in the February 28, 2018, online edition of the journal Nature that they had identified an alveolar epithelial progenitor (AEP) lineage, which was embedded in a larger population of epithelial cells called alveolar type 2 cells (AT2s). AEPs were shown to be a stable lineage during alveolar homeostasis but expanded rapidly to regenerate a large proportion of the alveolar epithelium after acute lung injury. AEPs exhibited a distinct transcriptome, epigenome, and functional phenotype and responded specifically to Wnt and fibroblast growth factor (FGF) signaling.

Human AEPs could be selectively isolated by targeting the conserved cell surface marker TM4SF1. Once isolated, these cells were used as functional human alveolar epithelial progenitor cells for growing three-dimensional lung organoids.

"From our organoid culture system, we were able to show that AEPs are an evolutionarily conserved alveolar progenitor that represents a new target for human lung regeneration strategies," said senior author Dr. Edward E. Morrisey, professor of cell and developmental biology at the University of Pennsylvania. "One of the most important places to better understand lung regeneration is in the alveoli, the tiny niches within the lung where oxygen is taken up by the blood and carbon dioxide is exhaled. To better understand these delicate structures, we have been mapping the different types of cells within the alveoli. Understanding cell-cell interactions should help us discover new players and molecular pathways to target for future therapies."

Related Links:
University of Pennsylvania

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer

Channels

Molecular Diagnostics

view channel
Image: The Monarch Mag Cell-free DNA (cfDNA) Extraction Kit provides isolation of low-abundance cfDNA from a range of biofluids (Photo courtesy of New England Biolabs)

New Extraction Kit Enables Consistent, Scalable cfDNA Isolation from Multiple Biofluids

Circulating cell-free DNA (cfDNA) found in plasma, serum, urine, and cerebrospinal fluid is typically present at low concentrations and is often highly fragmented, making efficient recovery challenging... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more